Advertisement
Screener

NASDAQ:ATHE | Research And Development Expense | ALTERITY THERAPEUTICS LTD

0.5 / 5 stars · 13/120 Roast Me

ALTERITY THERAPEUTICS LTD Research And Development Expense

Financial Statements › Expense Statement › Operating Expenses

ifrs-full:ResearchAndDevelopmentExpense · last filed 2025-08-29

Period endResearch And Development Expense 6 monthResearch And Development Expense 12 month
2025-06-3014.40M AUD
20-F · filed 2025-08-29
2024-06-3018.64M AUD
20-F · filed 2025-08-29
2023-06-3013.20M AUD
20-F · filed 2025-08-29
2022-06-3014.75M AUD
20-F · filed 2024-09-26
2021-12-316.76M AUD
6-K · filed 2022-02-28
2021-06-3012.28M AUD
20-F · filed 2023-08-31
2020-12-315.81M AUD
6-K · filed 2022-02-28
2020-06-3010.10M AUD
20-F · filed 2022-08-31
2019-12-315.75M AUD
6-K · filed 2021-02-25
2019-06-3012.98M AUD
20-F · filed 2021-09-02
2018-06-306.70M AUD
20-F · filed 2020-09-15
2017-06-305.70M AUD
20-F · filed 2019-08-30
2016-06-309.59M AUD
20-F · filed 2018-08-31